WebNov 19, 2024 · TAMPA, Fla. and BURLINGTON, Mass., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative... WebThere’s a simple solution: Flex Forward. Flex Forward provides an end-to-end customized solution for your multi-mode shipping with a single source for recovery, transportation, …
Flexion Therapeutics Announces Publication of Results from …
WebApr 1, 2024 · BURLINGTON, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has entered into an exclusive license agreement with HK Tainuo and Jiangsu... WebJul 14, 2024 · Flexion expects to report its complete second-quarter financial results in August. Conference Call Flexion’s management will host a conference call today at 8:30 a.m. ET. ... and the potential therapeutic and other benefits of ZILRETTA, are forward looking statements. These forward-looking statements are based on management’s … eacts 2020
Flexion Therapeutics Presents Clinical Data at AAOS 2024 Annual …
WebMar 29, 2024 · Pacira has three commercial-stage non-opioid treatments: EXPAREL (R) (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane ... WebSep 2, 2024 · This press release contains forward-looking statements that are based on the current expectations and beliefs of Flexion. Statements in this press release regarding matters that are not historical facts, including, but not limited to, statements relating to the future of Flexion; and the potential therapeutic and other benefits of ZILRETTA, are ... csharp inherit class